Validation of the Self-Assessment of Treatment Questionnaire among Patients with Postherpetic Neuralgia. (13th August 2012)

• Record Type: Journal Article
• Authors: Wyrwich, Kathleen W.; Kawata, Ariane K.; Thompson, Christine; Holmstrom, Stefan; Stoker, Malcolm; Wiklund, Ingela
• Other Names: Younger Jarred Academic Editor.
• Is Part Of: Pain research and treatment. Volume 2012(2012)
• Publication Date: 2012-08-13
• Subjects: Pain -- Periodicals; Pain -- Research -- Periodicals; Pain -- Prevention -- Periodicals; Pain -- Treatment -- Periodicals; 616.047205
• DOI: 10.1155/2012/621619
• Languages: English
• ISSNs: 2090-1542

Abstract

Abstract : Introduction . A five-item Self-Assessment of Treatment (SAT) was developed to assess improvement and satisfaction with treatment associated with the application of a novel high concentration 8% capsaicin topical patch in clinical trials in patients with postherpetic neuralgia (PHN). This study evaluated the item performance and psychometric properties of the SAT. Methods . The SAT, Brief Pain Inventory, SF-36v2, Short-Form McGill Pain Questionnaire, and Patient and Clinician Global Impression of Change (PGIC; CGIC) scores were measured in two 12-week Phase 3 clinical trials. Factor analysis assessed the underlying factor structure, followed by examination of the reliability and validity of the multi-item domain. Results . Pooled data from 698 patients completing SAT after 12 weeks of treatment were analyzed. A one-factor model combining three of the five items emerged as the optimal solution. Internal consistency reliability of this treatment efficacy factor was high (Cronbach's alpha = 0.89). Construct validity was demonstrated by moderate to high correlations with change in other study endpoints. SAT mean scores consistently discriminated between patient change groups defined by PGIC and CGIC. Conclusions . The measurement properties of the three-item version of SAT are valid and reliable for assessment of treatment with a high concentration capsaicin patch among patients with PHN.